Premium
Vasoactive intestinal peptide receptor expression in chronic periapical lesions
Author(s) -
CaviedesBucheli J.,
AzueroHolguín M. M.,
Moreno G. C.,
González I. L.,
Mateu E.,
Salazar J. F.,
Munoz H. R.
Publication year - 2007
Publication title -
international endodontic journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.988
H-Index - 119
eISSN - 1365-2591
pISSN - 0143-2885
DOI - 10.1111/j.1365-2591.2007.01250.x
Subject(s) - vasoactive intestinal peptide , lesion , receptor , medicine , dentistry , gastroenterology , periodontitis , pathology , neuropeptide
Aim To use radioreceptor analysis for evaluating whether vasoactive intestinal peptide (VIP) receptors are present in chronic periapical lesions and to determine whether differences in its expression are found according to the size of the lesions. Methodology Twelve periapical lesions were obtained from teeth diagnosed with chronic apical periodontitis and indicated for endodontic surgery; they were classified according to the size of the lesion in two groups of six samples (lesion size greater or smaller than 5 mm), and then processed and labelled with 125 I‐VIP. Binding sites were identified by 125 I‐VIP and standard VIP competition assays. Mann–Whitney's test was used to establish statistically significant differences in the VIP receptor expression between groups. Results Vasoactive intestinal peptide receptor expression was found in all periapical lesion samples. There was a statistically significantly higher expression in periapical lesions <5 mm ( P < 0.001). Conclusion Vasoactive intestinal peptide receptors were expressed in chronic periapical lesions with levels inversely proportional to lesion size.